Press Release from the cancer institute of new jersey
Contact: Courtney DeNicola
World’s Largest Cancer Research Organization Elects New President
American Association for Cancer Research Elects CINJ Director,
William N. Hait, M.D., Ph.D. as its New President-Elect
New Brunswick—William N. Hait, M.D., Ph.D., New Jersey
native and Director of The Cancer Institute of New Jersey (CINJ), has been voted
President-Elect of the American Association for Cancer Research (AACR), the world's
oldest and largest scientific organization dedicated to cancer research.
Effective April 3, Hait will assume this new role, in addition to remaining the editor-inchief of the AACR journal, Clinical Cancer Research. Beginning April 2007, Hait will
serve as president for one year, and will remain on the Executive Committee of the
AACR until April 2008, as past-president. The year 2007 is the 100th anniversary of the
inception of this prestigious organization whose mission is to accelerate the prevention
and cure of cancer.
For the past thirteen years, Hait has served as Director of CINJ, New Jersey's first and
only National Cancer Institute-designated Comprehensive Cancer Center, and as Associate Dean, Professor of Medicine and Pharmacology at UMDNJ-Robert Wood Johnson Medical School. As a medical oncologist specializing in the care of breast cancer patients, Hait conducts research with his patients in mind. His laboratory studies the determinants of sensitivity to anticancer treatments and signal transduction systems uniquely altered in malignant cells. This research spans molecular and cellular biology to tissue culture and animal models, ultimately improving the treatment of cancer patients.
"We are delighted that Dr. Hait has been elected to the Presidency of the AACR," said
Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "He is a highly
respected scientist and compassionate physician whose expertise in both laboratory and
clinical research will be very important in furthering our advances against cancer in this
new era of translational research and molecular targeted therapies."
We are proud of Dr. Hait's newly elected position which is reflective of the outstanding
research and leadership skills he possesses," stated Robert E. Campbell, Chairman of the
CINJ Board of Overseers. "His vision to have CINJ become one of the nation's leading
cancer centers has created an exemplary facility and resource for New Jersey."
Hait's commitment toward creating a cancer center of the highest quality has attracted
some the nation's most well-known and respected scientists and physicians. CINJ’s
faculty, most of whom are members of the AACR, are committed to research that can be
applied toward the ultimate benefit of cancer patients.
"The AACR stands as a beacon for those who understand and therefore value the
importance of excellence in research to the ultimate conquest of cancer," said Hait. "The
AACR offers cancer researchers their most natural professional home because of its
diverse scientific membership, and I am proud to be part of the new leadership."
Membership in the AACR surpasses 24,000, including basic, translational, and clinical
researchers, healthcare professionals, and patient advocates and cancer survivors in the
United States and abroad. Founded in 1907, the AACR marshals the full spectrum of
expertise from the cancer community to accelerate progress in the prevention, diagnosis
and treatment of cancer through high-quality scientific and educational programs,
communications, and funding meritorious research projects.
The Cancer Institute of New Jersey is the state’s first and only National Cancer Institutedesignated Comprehensive Cancer Center, and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice quite literally bringing research to life. The Cancer Institute of New Jersey is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
The Cancer Institute of New Jersey Network is comprised of hospitals throughout the
state and provides a mechanism to rapidly disseminate important discoveries into the
community. Partner Hospitals: Robert Wood Johnson University Hospital, Atlantic
Health System (Morristown Memorial Hospital, Mountainside Hospital, Overlook
Hospital). Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare
System, Cooper University Hospital (CINJ at Cooper),* Jersey Shore University Medical
Center, JFK Medical Center, Monmouth Medical Center, Raritan Bay Medical Center,
Robert Wood Johnson University Hospital at Hamilton (CINJ-Hamilton), Saint Peter’s
University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The
University Hospital/UMDNJ-New Jersey Medical School*, and University Medical
Center at Princeton.